Myriad Genetics

Presence


Myriad Genetics is one of the...

Myriad Genetics is a company listed under the stock ticker MYGN (US).

Myriad Genetics has a direct presence in 2 countries.

Myriad Genetics has 4 subsidiaries including GeneSight, Myriad Genetics Europe and Myriad RBM.

They are in:

Executives

View the org chart displaying its 43 main executives

Most searched biographies at Myriad Genetics
Popular executive movements at Myriad Genetics
  • George Daneker will join the company as President and Chief Clinical Officer of Oncology on Mar. 18, 2024  (posted on January 31 2024).
  • Bryan Riggsbee, Chief Financial Officer, will retire on Jan. 29, 2024  (posted on December 22 2023).
  • Scott Leffler will join the company as Chief Financial Officer on Mar. 31, 2024  (posted on December 22 2023).

Click here to view some more movements at Myriad Genetics

Create your alert
to follow the executive moves at Myriad Genetics.

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.